Goodrx Holdings, Inc. Stock Price, News & Analysis

GoodRx Holdings (GDRX) announced its participation in three upcoming virtual investor conferences. The events include the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 11:00 a.m. PT, the Citi 2021 Global Technology Virtual Conference on September 14 at 9:10 a.m. PT, and the Goldman Sachs 30th Annual Communacopia Conference on September 22 at 11:55 a.m. PT. Live webcasts and archived recordings will be accessible on their Investor Relations website. GoodRx, a leader in healthcare savings, has helped Americans save over $30 billion since 2011.

GoodRx Holdings (GDRX) announced its second quarter 2021 financial results on August 12, with a conference call scheduled to discuss the outcomes and future outlook. The company claims to have saved Americans over $30 billion since 2011, providing affordable healthcare services like telehealth and lab tests. GoodRx emphasizes its role as America’s leading resource for healthcare savings.

GoodRx, Inc. (Nasdaq: GDRX) and Boehringer Ingelheim have initiated a partnership to enhance access to copay programs for diabetes and COPD medications on the GoodRx platform. This collaboration aims to provide approximately $15 million in annual savings for patients in need of life-enhancing drugs. Diabetes impacts over 10% of the U.S. population, with medical costs considerably higher for affected individuals. With more patients facing increased financial burdens due to insurance changes, this initiative seeks to alleviate some of the cost barriers.

GoodRx (NASDAQ: GDRX) has formed a partnership with Surescripts to integrate drug discount pricing into Surescripts' Real-Time Prescription Benefit system. This collaboration aims to enhance prescription price transparency, particularly for uninsured patients and those lacking price information from their health plans. The initiative could lead to significant savings—up to 80%—on prescriptions, fostering better patient decision-making at the point of care. This effort aligns with GoodRx's mission to improve healthcare affordability for Americans.

GoodRx (NASDAQ: GDRX) recently published a consumer survey revealing its positive impact on pharmacy retailers. Key findings show that GoodRx enhances medication affordability, with 81% of users able to afford all prescriptions after using the service, compared to only 23% beforehand. Additionally, nearly 80% of users reported buying other items while picking up prescriptions, averaging $40 in extra purchases. The survey also indicated that 85% of participants were more likely to return to their pharmacy due to their positive experience with GoodRx, highlighting its role in boosting foot traffic and customer loyalty.

GoodRx Holdings (Nasdaq: GDRX) plans to release its Q2 2021 financial results on August 12, 2021, before U.S. markets open. A conference call will follow at 5:00 a.m. PT (8:00 a.m. ET) to discuss the results and business outlook. A shareholder letter and detailed financial results will be available on their investor relations website. GoodRx is recognized as America's leading resource for healthcare savings, having helped Americans save over $30 billion since 2011 and is the most downloaded medical app for the last three years.